Seed pre-Activation Study by Means of LED Radiation

To study the possibilities of pre-sowing seed activation, irradiation with LEDs emitting in the visible, violet, and near-ultraviolet ranges with a maximum of 405 nm was carried out. As a result of the growing experience, it was found that the height of wheat plants grown from the treated seeds significantly exceeds the control indicators except for the period of 45-55 days. To implement the flow, technology of seed activation with LEDs optoelectronic irradiation unit was developed. The advantages of the given installation are the energy efficiency and of seed treatment efficiency, due to of the optimal radiation spectrum selection and treatment doses.

Evaluation of the Effect of LED-Lamp Spectral Content on the Development of Greenhouse Tomato

The article reports the results of the experiment studied the effect of radiation spectral content (considering its equal intensity in terms of photosynthetically active radiation) on the growth and development of Boets greenhouse tomato breed. We have shown that the effective development of model subjects requires the adaptation of radiation spectral content depending on the growth period and type of a plant, unlike the illumination level. The obtained results demonstrate the necessity of creating an adaptive irradiation unit.

Risk of breast fibrosis following irradiation using a breast-specific SBRT system compared with conventional APBI.

116 Background: To determine the dosimetric characteristics and risk of breast fibrosis using a normal tissue complication probability (NTCP) model in conjunction with a novel preoperative stereotactic radiotherapy system called the GammaPod. Results are compared with linac based post-lumpectomy APBI plans for the same cohort. Methods: The GammaPod breast SBRT system consists of a Co-60 irradiation unit in combination with an immobilization device with embedded fiducials. Eight patients were enrolled in an IRB-approved protocol and underwent CT scans in the prone position with breast immobilization. A preoperative target (GTV) was synthesized to match the tumor location and volume reported in imaging studies obtained prior to surgery (0.3-2.4 cc). The GTV was expanded by 1.5 cm to create a CTV, and a PTV was created using an additional 0.3 cm margin. The PTV was prescribed 25.5 Gy in 3 fx, which is radiobiologically equivalent to conventional APBI doses of 38.5 Gy in 10 fx. Following the radioablative experience in NSCLC, we also planned to deliver 60.0 Gy to the GTV+0.3 cm as a simultaneous boost in conjunction with the 25.5 Gy PTV prescription dose. For comparison, linac-based treatment plans were created for the same cohort following NSABP B-39 guidelines. Whole breast dosimetry was analyzed in terms of biologically equivalent dose (BED) and Lyman NTCP analysis was performed. Results: The volume of ipsilateral breast receiving 10, 20, 50, and 100% of the prescribed dose was substantially smaller in GammaPod vs. APBI plans, with cohort averages of 19.3, 13.0, 7.1 and 4.0% vs. 75.8, 67.3, 48.1 and 27.6% respectively (p<0.001). Even though the PTV equivalent uniform BED (EUD) was substantially higher in GammaPod plans (87.9 Gy vs. 57.3 Gy), the ipsilateral breast EUD was still smaller in these plans, 18.9 ± 5.0 Gy vs. 47.2 ± 3.2 Gy (p<0.001). Corresponding NTCP predictions for breast fibrosis rates following GammaPod and APBI treatments were 0.2 ± 0.1% vs. 2.8 ± 0.8% (p<0.001), respectively. Conclusions: The GammaPod system improves upon traditional post-lumpectomy linac-based APBI by decreasing dose to the ipsilateral breast as well as the predicted rates of breast fibrosis.